Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Fulcrum Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- +5 vs. Q3 2022
- Shares held
- 50.6M
- −1.55M (−3.0%) vs. Q3 2022
- Total value
- $368.5M
- −$53.6M (−12.7%) vs. Q3 2022
- New holders
- 22
- 47 more added
- Sold out
- 17
- 25 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cowen and Company, LLC | 1,361,169 | $9.91M | 1.05% | −986,820−42.0% | Reduced |
| TRV GP III, LLC | 1,962,202 | $14.3M | 11.20% | −2,000,000−50.5% | Reduced |
| Logos Global Management LP | 2,000,000 | $14.6M | 1.71% | +50,000+2.6% | Added |
| Vanguard Group Inc | 2,120,623 | $15.4M | 0.00% | +164,531+8.4% | Added |
| TRV GP IV, LLC | 2,343,154 | $17.1M | 7.25% | 00.0% | Unchanged |
| BlackRock Inc. | 3,268,991 | $23.8M | 0.00% | +496,647+17.9% | Added |
| Suvretta Capital Management, LLC | 4,274,803 | $31.1M | 1.31% | +746,803+21.2% | Added |
| RTW Investments, LP | 4,993,279 | $36.4M | 0.74% | +1,007,369+25.3% | Added |
| FMR LLC | 5,233,725 | $38.1M | 0.00% | −2,571,917−32.9% | Reduced |
| Ra Capital Management, L.P. | 9,505,925 | $69.2M | 1.40% | +2,505,925+35.8% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,494,003−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −294,118−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −20,857−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −17,879−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −15,610−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,886−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,652−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,006−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −9,551−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −9,176−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −880−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −258−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −65−100.0% | Sold out |